Immunology. NK cells lose their inhibition.
Parham
Peter
P
Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. peropa@stanford.edu
D015236:HLA-C Antigens / Q000235:genetics / Q000276:immunology*; D016174:Hepacivirus / Q000276:immunology* / Q000502:physiology; D006526:Hepatitis C / Q000235:genetics / Q000276:immunology* / Q000635:transmission / Q000821:virology; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006720:Homozygote; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D008024:Ligands; D008099:Liver / Q000276:immunology / Q000821:virology; D008213:Lymphocyte Activation; D011971:Receptors, Immunologic / Q000235:genetics / Q000378:metabolism*; D054340:Receptors, KIR; D054342:Receptors, KIR2DL1; D013154:Spleen / Q000276:immunology / Q000821:virology; D014761:Viral Hepatitis Vaccines; D014766:Viremia; D014779:Virus Replication
D015236:HLA-C Antigens; D015395:Histocompatibility Antigens Class I; D008024:Ligands; D011971:Receptors, Immunologic; D054340:Receptors, KIR; D054342:Receptors, KIR2DL1; D014761:Viral Hepatitis Vaccines